Curriculum Vitae - Dr Kenneth John HARVEY
Total Page:16
File Type:pdf, Size:1020Kb
Curriculum Vitae - Dr Kenneth John HARVEY Contact Details Medreach Pty. Ltd. 35a Mary St. Hawthorn, Victoria, 3122, Australia Mobile: +61 4 1918 1910, VOIP: 03 9029 3697 E-mail: [email protected] and [email protected] WWW: https://www.medreach.com.au/ Date of Birth 26th June, 1944 Marital Status Married (Dr Jenny Harvey); three adult children, all university graduates, 4 grandchildren. Qualifications MB BS (1967); FRCPA (1975); MASM (1984) Current Medical Board of Australia Registration (Teaching and Assessing): MED0000996411. Current Position Honorary Adjunct Associate Professor, Bond University President, Fiends of Science in Medicine Director, Medreach Pty. Ltd. Special Interests Health Services Research, specifically: • Therapeutic Goods and Services Policy and Regulation (including Complementary Therapies) o Quality of goods and services o Equity of access o Viable and responsible industry (Ethical promotion) o Quality of use (Rational use) • Science advocacy o Friends of Science in Medicine • Consumer advocacy o Choice (Australian Consumer Association) o Consumers Health Forum. Professional • Member of the group of experts that devised the 1988 World Health Organization, Ethical Achievements Criteria for Medicinal Drug Promotion • Founding member, and at various times author, Chair of Antibiotic Writing Group and Board Member of Therapeutic Guidelines Limited • Inaugural member of the PHARM committee that devised the Quality Use of Medicines (QUM) plank of Australian Medicinal Drug Policy • Awarded life membership of CHOICE (Australian Consumers' Association) for services to the consumer movement (also CHOICE 2012 Consumer champion) • Awarded life membership of the Australian Skeptics for recognition of relentless campaigning against schlocky medical products and claims. • Chair of the Governing Council of Health Action International, Asia Pacific (HAIAP) • Awarded ANZAAS Medal 2016. For contribution to science which go beyond normal professional activities • Awarded Member (AM) in the General Division of the Order of Australia, 2017 for significant service to community health and the pharmaceutical industry through roles in developing guidelines for the ethical use of antibiotics • Elected President, Friends of Science in Medicine, 2019. Previous • Resident Medical Officer, Port Moresby General Hospital, Territory of Papua & New Positions Guinea, (1968) • Pathology Registrar (Microbiology), The Prince Henry and Prince of Wales Hospital Group, Sydney, (1969-72) • Registrar in Medical Computing, New South Wales Health Department -The Prince Henry and Prince of Wales Hospital Group, Sydney (1973) • Trainee in Microbiology, Victorian Hospitals and Charities Commission (1974-75) • Medical Clinical Assistant, The Royal Melbourne Hospital, (1975-76) • Assistant Microbiologist, The Royal Melbourne Hospital (1976-84) • Director of Microbiology, The Royal Melbourne Hospital (1984-87) • External Drug Evaluator, Therapeutic Goods Administration (1985-91) • Senior Lecturer, School of Public Health, La Trobe University (1990-2005) • Honorary Senior Research Fellow, School of Information Technology & Mathematical Sciences, University of Ballarat (2001-2010) • Adjunct Senior Lecturer, School of Public Health, La Trobe University (2006-2011) • Adjunct Associate Professor, School of Public Health, La Trobe University (2012-2014) Page 1 of 20 Curriculum Vitae - Dr Kenneth John HARVEY • Australian Director, AusAID Philippines National Drug Policy Cooperation Project (1993-97) • Board Member, Therapeutic Guidelines Limited (1997-2004) • WHO Fellow: Rational Drug Use - Malaysia, Bangladesh, China (2000) • Council Member, Australian Consumers Association (2000-2005) • Consultant, Australian Health Insurance Commission (now Medicare Australia): Croatian and Jordan Pharmaceutical Reform (2003-2006) • Consultant, USAID-PHRplus: Jordan Pharmaceutical Reform (2005-06) • Consultant, Medicare Australia. An Economic & Equity Impact Review of Australian National Pharmaceutical System Models. Pharmaceutical Reform Working Group Steering Committee (2006) • Adjunct Senior Lecturer, School of Public Health, La Trobe University (2006-2011) • Adjunct Associate Professor, School of Public Health, La Trobe University (2012- 2014) • Adjunct Associate Professor, School of Public Health and Preventive Medicine, Monash University (2014-2016) • Assoc Professor, School of Public Health and Preventive Medicine, Monash University (2017-2020). Overseas Bangladesh, China, Croatia, Hong Kong, India, Indonesia, Jordan, Laos, Malaysia, Experience Pakistan, Papua & New Guinea, Philippines, Singapore, Sri Lanka, Thailand, Vietnam. Committees • NH&MRC Medical Research Committee. (Past) • Therapeutic Goods Administration, Laboratory Advisory Committee. • Therapeutic Goods Advertising Code Council (Media Council of Australia). • Pharmaceutical Health and Rational Use of Medicines (PHARM) Committee, PHARM- Industry group and PHARM-Evaluation subcommittee of the Commonwealth Department of Community Services and Health. • WHO Expert Working Party that devised Ethical Criteria for Medicinal Drug Promotion • Organising Committee, International Conference on National Medicinal Drug Policies (WHO-Australian Government) 1995 • International Coordinating Committee, People's Health Assembly 2000 • Commonwealth Immunisation E-Handbook (8th edition) Working Party • General Practice Computer Group, Chronic Disease Management Working Group (2004- 2005). • Organising Committee, HAIAP, National Workshop on Rational Use of Antibiotics in China (2005) • Co-Chair, IT14-2-1, Standards Australia Pharmacy Concept Terminology (2005-2008). • Member, Research and Development Working Group and Electronic Prescribing Study Guidance Group, Australian National Prescribing Service (2006-11) • Member, Policy Advisory Group, Australian Consumers Association (2006-2012) • Member, Australian Government Working Group on Promotion of Therapeutic Products (2010-2011) • Member, Therapeutic Goods Administration Transparency Review Panel, (2010-2011) • Member, Scientific Program Committee, Asia Pacific Conference on National Medicines Policies 2012. • Chair, Governing Council, Health Action International Asia Pacific (2010-2013) • Member, Therapeutic Goods Administration, Business Process Reform CEO Forum (2011-2013) • Member, Australian Government Working Group on Regulatory Reform of Complementary Medicines (2011-2013) • Government’s Natural Therapy Review Advisory Committee (representing the Consumer Health Forum) (2013-2014) • Medicines Australia Code Review Panel (representing consumer interests) (2013-2014) • RACP Ethical Guidelines Working Party (2011-2014). • Choice representative on the Therapeutic Goods Advertising Consultative Council 2019- 2020. Past Board • 2000-2005: Australian Consumers Association Memberships: • 1997-2004: Therapeutic Guidelines Limited. Page 2 of 20 Curriculum Vitae - Dr Kenneth John HARVEY Current • Choice - Australian Consumers Association (Life member). Membership of • Australian Skeptics (Life member) Organisations & • Consumers Health Forum. Professional • Friends of Science in Medicine (President) Societies • Health Action International - Asia Pacific (HAIAP) • Public Health Association of Australia • Doctors for the Environment Australia. Publications • PHARM Evaluation Sub-committee (Gilbert A, Brooks C, Corti B, Harvey K, Harvey R, Books James M, Murray M, Primrose J, Swift D.) Manual of Indicators to measure the effect of initiatives under the Quality Use of Medicine arm of the National Medicinal Drug Policy. Australian Government Publishing Service, Canberra 1995. • Harvey KJ (Chairman), Beavis M, Christiansen K, Collignon P, Currie B, Dartnell J, Ferguson J, Harkness J, Isaacs D, Khariwala B, Kucers A, Looke D, Spicer WJ, Tosolini FA, Turnidge J. Antibiotic Guidelines 10th Ed. Therapeutic Guidelines Ltd., Melbourne 1998 (and also involvement in the first edition and a number of previous editions). • Roughead EE, Gilbert AL, Primrose JG, Harvey KJ, Sansom LN. Report of the national indicators: Evaluating the quality use of medicines component of Australia's National Medicines Policy. Publications Production Unit, Commonwealth Department of Health and Aged Care, Canberra, 1999. Book chapters • Harvey K, Murray M. Medicinal drug policy, in The Politics of Health, 2nd Ed., Gardner H (Ed) Churchill Livingstone, Melbourne, 1995, 238-283. • Harvey KJ. Drug Promotion, in Drugs in the Health Marketplace. Komesaroff PA, Wiltshire J. (Ed) Arena Publications, Melbourne 1997, 47-70. • Aroni R, de Boer R, Harvey K. The Viagra Affair. In Evidence-based Health Policy, Edited by Lin V & Gibson B. Oxford University Press, Melbourne 2003, 97-109. • Löfgren H, Harvey K. The Pharmaceutical Benefits Scheme, in Understanding the Australian Health Care System, 2nd Ed. Willis E, Reynolds L, Keleher H. (Ed) Churchill Livingstone Elsevier, Sydney, (publication date: early 2012). • Harvey K. Regulation of Complementary Medicines, in Perspectives on complementary and alternative medicines, Edited by Prof Ian Olver & Monica Robotin, Imperial College Press, Oct 2011. Editorials • King K, Harvey K. MRSA Revisited (Editorial). Med J Aust 1985; 2: 88-89. • Darvall L, Harvey KJ Australian pharmaceutical advertising: a critique (Editorial). Med J Aust 1985; 2:272-274. • Harvey K. Quality assurance of therapeutic products and practice (Editorial). Med J Aust 1987; 147: 317. • Harvey K, Rogers S, Roughead L. Initiatives to improve antibiotic use (Editorial). Aust Presc 1999; 22: 26-28. • Harvey